Medicaid Coverage of Continuous Glucose Monitors
Florida bill to expand Medicaid coverage of continuous glucose monitors for diabetic patients died in committee due to fiscal concerns over implementation costs.
Florida bill to expand Medicaid coverage of continuous glucose monitors for diabetic patients died in committee due to fiscal concerns over implementation costs.
SB 1182 would have required Florida's Medicaid program to cover continuous glucose monitors (CGMs) for eligible beneficiaries with diabetes. The bill aimed to expand access to this technology, which provides real-time blood sugar monitoring without fingerstick testing. However, the bill died in the Fiscal Policy Committee after being indefinitely postponed.
CGMs significantly improve diabetes management outcomes and quality of life, particularly for patients with Type 1 diabetes and insulin-dependent Type 2 diabetes. The bill's failure means Florida Medicaid beneficiaries with diabetes may continue facing barriers to accessing this technology, potentially resulting in worse health outcomes and higher long-term medical costs. This is especially consequential given that Medicaid covers many low-income Floridians with limited ability to purchase CGMs privately.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.